27 April 2023
Latham & Watkins Advises Assertio Holdings in Acquisition of Spectrum Pharmaceuticals
Advising firms
Deal team
36 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Zachary Judd Lead | Latham & Watkins LLP | Partner | corporate | Chicago |
| Owen Alexander Lead | Latham & Watkins LLP | Partner | corporate | Chicago |
| Michael Magstadt | Latham & Watkins LLP | Associate | corporate | Not stated |
| Autumn Schmidt | Latham & Watkins LLP | Associate | corporate | Not stated |
| Serena Su | Latham & Watkins LLP | Associate | corporate | Not stated |
| Cathy Birkeland | Latham & Watkins LLP | Partner | public company representation | Chicago |
| Jonathan Sarna | Latham & Watkins LLP | Partner | public company representation | Chicago |
| Andrew Rutsky | Latham & Watkins LLP | Associate | public company representation | Not stated |
| Omeed Valipour | Latham & Watkins LLP | Associate | public company representation | Not stated |
| Rene de Vera | Latham & Watkins LLP | Partner | tax | Chicago |
| Chris Ohlgart | Latham & Watkins LLP | Associate | tax | Not stated |
| Benjamin Rosemergy | Latham & Watkins LLP | Partner | executive compensation and benefits | Chicago |
| Jina Davidovich | Latham & Watkins LLP | Associate | executive compensation and benefits | Not stated |
| Joe Gu | Latham & Watkins LLP | Associate | executive compensation and benefits | Not stated |
| Julia Hatcher | Latham & Watkins LLP | Partner | environmental | Washington, D.C. |
| Andrew Landolfi | Latham & Watkins LLP | Associate | environmental | Not stated |
| Robert Buday | Latham & Watkins LLP | Partner | real estate | Chicago |
| Karen Ritter | Latham & Watkins LLP | Associate | real estate | Not stated |
| Ben Haas | Latham & Watkins LLP | Partner | FDA regulatory | Washington, D.C. |
| Seth Olson | Latham & Watkins LLP | Associate | FDA regulatory | Not stated |
| Steven Chinowsky | Latham & Watkins LLP | Partner | intellectual property | San Diego |
| Darryl Steensma | Latham & Watkins LLP | Counsel | intellectual property | San Diego |
| Robert Yeh | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Robert Blamires | Latham & Watkins LLP | Partner | data privacy | Bay Area |
| Kathryn Parsons-Reponte | Latham & Watkins LLP | Associate | data privacy | Not stated |
| Dyllan Brown-Bramble | Latham & Watkins LLP | Associate | data privacy | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare regulatory | Bay Area |
| Yanyan Zhou | Latham & Watkins LLP | Associate | healthcare regulatory | Not stated |
| Leia Gu | Latham & Watkins LLP | Associate | healthcare regulatory | Not stated |
| Noah Weiss | Latham & Watkins LLP | Partner | finance | Chicago |
| Colin O'Regan | Latham & Watkins LLP | Counsel | finance | Chicago |
| Nicholas Siciliano | Latham & Watkins LLP | Partner | securities | Chicago |
| Heather Waller | Latham & Watkins LLP | Partner | securities | Chicago |
| Amanda Reeves | Latham & Watkins LLP | Partner | antitrust | Washington, D.C. |
| Jason Daniels | Latham & Watkins LLP | Counsel | antitrust | Bay Area |
| Britton Davis | Latham & Watkins LLP | Counsel | antitrust | Washington, D.C. |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Assertio Holdings, Inc.Buy-side
- Counterparties
- Spectrum Pharmaceuticals, Inc. (Sell-side)